Your session is about to expire
← Back to Search
Behavioral Intervention
Prism Adaptation Therapy for Stroke Rehabilitation
N/A
Recruiting
Led By Anna M. Barrett, MD
Research Sponsored by VA Office of Research and Development
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Has had a first right brain stroke >18 years of age
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 5 weeks after enrollment
Awards & highlights
Study Summary
This trial will test a brain scan to help Veterans after a right brain stroke to recover the ability to do daily activities.
Who is the study for?
This trial is for Veterans over 18 who've had their first right brain stroke within the last 1-4 months. They must be able to sit up, have vision better than 20/50 in both eyes, and give informed consent. It's not for those with other neurological disorders like Alzheimer's, previous left brain strokes or significant prior strokes visible on scans.Check my eligibility
What is being tested?
The study tests Prism Adaptation Therapy (PAT) as a rehabilitation method for spatial neglect after a right brain stroke. The therapy involves visuomotor training while wearing optical prisms over a period of ten days. Researchers aim to develop a brain scan test to identify candidates for PAT.See study design
What are the potential side effects?
While specific side effects are not detailed here, PAT generally involves visual distortion through prisms which may cause initial disorientation or discomfort but typically adapts over time during therapy.
Eligibility Criteria
Inclusion Criteria
You may be eligible if you check “Yes” for the criteria belowSelect...
I had a stroke on the right side of my brain as an adult.
Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Functional independence Measure (FIM) improvement trajectory
Spatial neglect (SN) type (Aiming SN versus Where SN)
Secondary outcome measures
SN severity, as assessed by the Behavioral Inattention Test-conventional subtest (BIT-c)
SN severity, as assessed by the Catherine Bergego Scale (CBS)
Trial Design
2Treatment groups
Active Control
Group I: No spatial neglectActive Control1 Intervention
People without spatial neglect symptoms will not receive an intervention for spatial neglect.
Group II: Prism adaptation TherapyActive Control1 Intervention
People with spatial neglect will receive this effective treatment to reduce symptoms, which the investigators' previous work indicated may be particularly effective for Aiming SN symptoms.
Find a Location
Who is running the clinical trial?
VA Office of Research and DevelopmentLead Sponsor
1,611 Previous Clinical Trials
3,305,040 Total Patients Enrolled
2 Trials studying Spatial Neglect
57 Patients Enrolled for Spatial Neglect
Anna M. Barrett, MDPrincipal InvestigatorVA Central Western Massachusetts Healthcare System, Leeds, MA
1 Previous Clinical Trials
45 Total Patients Enrolled
1 Trials studying Spatial Neglect
45 Patients Enrolled for Spatial Neglect
Media Library
Eligibility Criteria:
This trial includes the following eligibility criteria:- You have poor vision, seeing less clearly than most people.I have a chronic neurological condition like MS or Alzheimer's.I can sit up, see clearly with both eyes, and point to objects.I have had a stroke on the left side of my brain or scans show I've had strokes.I am unable to sit up for tests or treatments.I was diagnosed with a right brain stroke 1-4 months ago.I had a stroke on the right side of my brain as an adult.
Research Study Groups:
This trial has the following groups:- Group 1: No spatial neglect
- Group 2: Prism adaptation Therapy
Awards:
This trial has 1 awards, including:- No Placebo-Only Group - All patients enrolled in this study will receive some form of active treatment.
Timeline:
This trial has the following timeline:- Screening: It may take up to 3 Weeks to process to see if you qualify in this trial.
- Treatment: The duration you will receive the treatment varies.
- Follow Ups: You may be asked to continue sharing information regarding the trial for 6 Months after you stop receiving the treatment.
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are there any open recruitment slots for this research endeavor?
"Clinicaltrials.gov reveals that this clinical trial is still seeking participants; the initial posting being on February 1st 2023 and most recently revised on August 7th, 2023."
Answered by AI
How many patients are being accepted into this trial?
"Affirmative. According to information listed on clinicaltrials.gov, this trial is actively recruiting; it was initially posted online in February 1st of 2023 and updated lastly on August 7th of the same year. In total, 244 participants are needed from 3 distinct medical locations."
Answered by AI
Share this study with friends
Copy Link
Messenger